Trial
NCT05960565
Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
St. Olavs Hospital
Collaborators
—
Condition
Type 1 Diabetes
Intervention
Glucagon
Why stopped
No sign of the anticipated effect.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-13